English  |  正體中文  |  简体中文  |  Total items :2814562  
Visitors :  27305965    Online Users :  645
Project Commissioned by the Ministry of Education
Project Executed by National Taiwan University Library
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
About TAIR

Browse By

News

Copyright

Related Links

"lien m y"

Return to Browse by Author
Sorting by Title Sort by Date

Showing items 1-10 of 21  (3 Page(s) Totally)
1 2 3 > >>
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2022-09-15T01:09:06Z Neutrophil-to-lymphocyte Ratio and Use of Antibiotics Associated With Prognosis in Esophageal Squamous Cell Carcinoma Patients Receiving Immune Checkpoint Inhibitors Guo J.-C.; Chia-Chi Lin; Lin C.-Y.; Hsieh M.-S.; Kuo H.-Y.; Lien M.-Y.; Shao Y.-Y.; Huang T.-C.; Hsu C.-H.
臺大學術典藏 2022-09-15T01:08:47Z Response to Immune Checkpoint Inhibitors in Recurrent or Metastatic Esophageal Squamous Cell Carcinoma May Be Affected by Tumor Sites Guo J.-C.; Lin C.-Y.; Chia-Chi Lin; Huang T.-C.; Lien M.-Y.; Lu L.-C.; Kuo H.-Y.; Hsu C.-H.
臺大學術典藏 2022-08-19T06:48:44Z Response to Immune Checkpoint Inhibitors in Recurrent or Metastatic Esophageal Squamous Cell Carcinoma May Be Affected by Tumor Sites Guo J.-C.; Lin C.-Y.; Lin C.-C.; Huang T.-C.; Lien M.-Y.; Lu L.-C.; Kuo H.-Y.; CHIH-HUNG HSU
臺大學術典藏 2022-03-15T03:29:02Z Response to Immune Checkpoint Inhibitors in Recurrent or Metastatic Esophageal Squamous Cell Carcinoma May Be Affected by Tumor Sites Guo J.-C.; Lin C.-Y.; Lin C.-C.; TA-CHEN HUANG; Lien M.-Y.; Lu L.-C.; Kuo H.-Y.; Hsu C.-H.
臺大學術典藏 2022-03-10T02:31:38Z Safety and efficacy of pegylated liposomal doxorubicinbased adjuvant chemotherapy in patients with stage I-III triple-negative breast cancer Lien M.-Y.; Liu L.-C.; Wang H.-C.; Yeh M.-H.; Chen C.-J.; Yeh S.-P.; Bai L.-Y.; Liao Y.-M.; Lin C.-Y.; Hsieh C.-Y.; Lin C.-C.; Li L.-Y.; PO-HAN LIN; Chiu C.-F.
臺大學術典藏 2022-03-10T02:31:36Z A targeted next-generation sequencing in the molecular risk stratification of adult acute myeloid leukemia: implications for clinical practice PO-HAN LIN; Li H.-Y.; Fan S.-C.; Yuan T.-H.; Chen M.; Hsu Y.-H.; Yang Y.-H.; Li L.-Y.; Yeh S.-P.; Bai L.-Y.; Liao Y.-M.; Lin C.-Y.; Hsieh C.-Y.; Lin C.-C.; Lin C.-H.; Lien M.-Y.; Chen T.-T.; Ni Y.-H.; Chiu C.-F.
臺大學術典藏 2022-02-07T03:29:04Z Response to Immune Checkpoint Inhibitors in Recurrent or Metastatic Esophageal Squamous Cell Carcinoma May Be Affected by Tumor Sites Guo J.-C.; Lin C.-Y.; Lin C.-C.; Huang T.-C.; Lien M.-Y.; Lu L.-C.; Kuo H.-Y.; CHIH-HUNG HSU
臺大學術典藏 2022 B Cells in Tumor Microenvironment Associated With The Clinical Benefit to Programmed Cell Death Protein-1 Blockade Therapy in Patients With Advanced Esophageal Squamous Cell Carcinoma Hsu C.-L.; Huang Y.-L.; Lin C.-C.; Huang T.-C.; Wu I.-C.; Lin C.-Y.; Lien M.-Y.; Kuo H.-Y.; Cheng A.-L.; CHIH-HUNG HSU; Guo J.-C.
臺大學術典藏 2022 Deleterious alterations of DNA damage response and repair genes and clinical benefit to anti-PD-1 therapy in esophageal squamous cell carcinoma CHIH-HUNG HSU; Cheng A.-L.; Lien M.-Y.; Kuo H.-Y.; Lin C.-Y.; Huang T.-C.; Hsu C.-L.; Lin C.-C.; Guo J.-C.
臺大學術典藏 2021-08-18T07:39:05Z Neutrophil-to-lymphocyte Ratio and Use of Antibiotics Associated With Prognosis in Esophageal Squamous Cell Carcinoma Patients Receiving Immune Checkpoint Inhibitors JHE-CYUAN GUO; Lin C.-C.; Lin C.-Y.; Hsieh M.-S.; Kuo H.-Y.; Lien M.-Y.; Shao Y.-Y.; Huang T.-C.; Hsu C.-H.

Showing items 1-10 of 21  (3 Page(s) Totally)
1 2 3 > >>
View [10|25|50] records per page